£3.0M
The Edinburgh spinout will use the capital to launch new programmes and establish its operational footprint.
Concinnity Genetics builds artificial intelligence platforms to improve the safety of gene therapies.
Concinnity Genetics is an Edinburgh-based biotechnology company developing advanced control systems for cell and gene therapies.
Cash at bank
Net assets
Shareholders' funds
Employees
Cash, assets and headcount from Concinnity Genetics's latest Companies House filing — with year-on-year movement, free with a Winfred account.

Jessica Birt
CEO and Co-founder
Jessica is the chief executive officer and co-founder of Concinnity Genetics. She previously completed a bioengineering PhD at the University of Edinburgh.
LinkedInThe Edinburgh spinout will use the capital to launch new programmes and establish its operational footprint.